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1. Introduction 
Recently we have found [l] that injection of N6, 
02’-dibutyryl cyclic adenosine 3’,5’-monophosphate 
(DBcAMP) into adrenalectomized rats initially stimul- 
ated hepatic phosphoenolpyruvate carboxykinase 
(PEP-CK, EC 4.1.1.32) and tyrosine aminotransferase 
(TAT, EC 2.6.1.5) to the same degree as in intact rats. 
However, despite of repeated DBcAMP administration 
the raise in the activity of both enzymes ceased after 
2 hr, but could be restored when hydrocortisone had 
been given at zero time. These results suggested that 
the maintenance of CAMP-mediated induction of 
PEP-CK and TAT is dependent on the simultaneous 
presence of glucocorticoids. 
Because of the obvious complications associated 
with whole animal experiments the hypothesis was 
now re-examined in the isolated perfused rat liver. 
It could be demonstrated that the interaction between 
CAMP and glucocorticoids, in fact, occurred as the 
result of direct participation of the administered agents 
at the tissue level. Moreover, our in vitro findings 
support the hypothesis derived from previous in viva 
studies [ 11, that CAMP elevates PEP-CK and TAT by 
a mechanism which, in principle, works independently 
from glucocorticoids while glucocorticoids stimulate 
a different process that is required for the maintenance 
of CAMP-mediated enzyme induction. 
2. Materials and methods 
Male Wistar rats, weighing 200 g each, purchased 
from E. Jautz, Kisslegg/Allgau (Germany) were used 
as liver donors. Prior to the experiments intact animals, 
kept on a standard chow diet, were fed ad libitum on 
a low protein diet (C 1004; Altromin GmbH, Lage/ 
Lippe, Germany) for 3 days. Adrenalectomized rats, 
given 0.9% NaCl solution as drinking water, were fed 
ad libitum on a standard chow diet for 4 days and, 
thereafter, on a low protein diet for 3 days. 
At the beginning of the perfusion experiments 
(8.00 a.m.) animals were anaesthetized by intraperiton- 
eal injection of hexobarbital(l5 mg/lOO g body wt). 
Livers were isolated and perfused by the technique of 
Schimassek [2] with a 10% (v/v) emulsion of fluoro- 
carbon 43, made up in the non-ionic detergent 
Pluronic F 68 by sonication and diluted with a saline 
buffer. Further details of the preparation of the 
fluorocarbon medium have been described previously 
[3]. The perfusate volume was 150 ml containing 135 
ml of the fluorocarbon medium, 15 ml of pig plasma 
and 100 mg of glucose/ 100 ml. 
The plasma was prepared from either intact or 
adrenalectomized miniature pigs ‘Gottingen’ (Max- 
Planck-Institut fur Versuchstierzucht, Gottingen, 
Germany), adrenalectomy being performed 4 days 
prior to plasma preparation. The pigs were killed by 
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a striker and exsanguinated by heart puncture. The 
heparinized blood was centrifuged at 2000 g (4°C). 
Plasma sufficient for all perfusion experiments was 
pooled from several animals and stored deep-frozen. 
The absence of glucocorticoids from the plasma of 
adrenalectomized pigs has been ascertained by the 
method of Blunck and Willig [4]. In the experiments 
depicted in figs. 1 and 2 plasma obtained from intact 
pigs was employed for the perfusion of livers from 
intact rats, and plasma obtained from adrenalectomiz- 
ed pigs was employed for the perfusion of livers 
from adrenalectomized rats. 
After 15 min of perfusion one liver lobe was ligated 
at its base and excised. Then DBcAMP and/or dexame- 
thasone was added to the reservoir at zero time to 
give the final concentrations indicated in the legend 
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to fig.l. At 2, 4 and 6 hr further liver lobes were 
removed. 
Tissue was immediately homogenized in 7 vol of 
an ice cold 0.15 M KC1 solution in a glass Potter- 
Elvehjem homogenizer with a Teflon pestle at 1000 
rev/min for 30 s. The homogenate was centrifuged 
at 150 000 g for 30 min at 0°C and PEP-CK activity 
was immediately assayed in the supernatant by the 
method of Seubert and Huth [5]. Enzyme activity 
(U) is expressed as pmol oxaloacetate converted to 
phosphoenolpyruvate per min at 37’C under the 
conditions of the assay. TAT activity was determined 
in the supernatant 24 hr later according to Diamand- 
stone [6] using a modification based on the results 
of Wurtman and Larin [7] . One unit of enzyme activity 
is defined as the amount of enzyme required to form 
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Fig.1. Time course of effects of dibutyryl cyclic AMP and/or dexamethasone on hepatic phosphoenolpyruvate carboxykinase 
activity in the isolated perfused liver of intact and adrenalectomized rats. Perfusion was performed as described under ‘Materials 
and methods’. Dibutyryl cyclic AMP (DBcAMP, 0.2 mM) and/or dexamethasone (50 PM) was added to the medium in the 
reservoir at zero time. For control, n = 5; for dexamethasone, n = 4; for DBcAMP, n = 7; for DBcAMP + dexamethasone, n = 7. 
Values are given as means + SEM. SEM was determined for all data points, but in several cases the brackets were too small to be 
conveniently included in the drawing. Statistical analysis: Intact: Dexamethasone values, 2,4 and 6 hr versus control: non 
significant (= n.s.), p < 0.0005 and p < 0.0025. DBcAMP values, 2, 4 and 6 hr versus control: p < 0.0025, p < 0.0005 and 
p < 0.0005. DBcAMP + dexamethasone values, 2,4 and 6 hr versus control: p < 0.0005. DBcAMP + dexamethasone values, 2,4 
and 6 hr versus DBcAMP: n.s., n.s. and p < 0.005. Adrenalectomy: Dexamethasone values, 2,4 and 6 hr versus control: n.s., n.s. 
and p 0.025. DBcAMP values, 2, 4 and 6 hr versus control: p < 0.005, p < 0.0025 and p < 0.0025. DBcAMP + dexamethasone 
values 2,4 and 6 hr versus control: p < 0.025, p < 0.0025 and p < 0.005. DBcAMP + dexamethasone values, 2,4 and 6 hr versus 
DBcAMP: n.s., p < 0.0005 and p < 0.0005. 
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1 pmol of p-hydroxyphenylpyruvate per min at 37°C 
under the conditions of the assay. Protein was 
measured by the biuret method [8]. The significance 
of differences between means was established by 
Student’s t test. Substrates, nucleotides (including 
DBcAMP) and test enzymes were purchased from 
C. F. Boehringer and Soehne GmbH (Mannheim, 
Germany). Dexamethasone (Fortecortin) was obtained 
from Hoechst AG (Frankfurt/Main-Hoechst, Germany). 
3. Results 
In livers from adrenalectomized rats stimulation of 
PEPCK and TAT due to dexamethasone or dexame- 
thasone t DBcAMP revealed identical results when 
plasma from either adrenalectomized or intact pigs 
was employed for the perfusion experiments. This 
independence from the choice of plasma donors was 
also true for the perfusion of livers from intact rats. 
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Figs. 1 and 2 present the effects of dexamethasone, 
DBcAMP, and dexamethasone t DBcAMP on the 
activities of both enzymes, which were studied in the 
isolated liver of intact or adrenalectomized rats 
perfused with a fluorocarbon medium containing 
plasma from intact or adrenalectomized pigs, respec- 
tively. In livers taken from intact rats addition of 
dexamethasone (50 PM) to the perfusion medium 
significantly raised PEFCK activity up to 142% after 
6 hr (fig. 1). DBcAMP at a concentration of 0.2 mM 
provoked a more rapid and more effective elevation 
in enzyme activity which continued to increase 
linearly throughout the duration of the experiment. 
Combination of dexamethasone and DBcAMP produc- 
ed no greater response than did DBcAMP alone. In 
livers taken from adrenalectomized rats dexamethasone 
elicited the same degree of elevation in PEP-CK 
activity asin livers from intact rats. Also, adrenalec- 
tomy of the liver donors did not reduce the response 
of the enzyme to DBcAMP during the first 2 hr of 
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Fig.2. Time course of effects of dibutyryl cyclic AMP and/or dexamethasone on hepatic tyrosine aminotransferase activity in the 
isolated perfused liver of intact and adrenalectomized rats. For further details see legend to fig. 1. Values are given as means f
SEM. Statistical analysis: Intact: Dexamethasone values 2, 4 and 6 hr versus control: ns., p < 0.0005 and p < 0.0025. DBcAMP 
values, 2,4 and 6 hr versus control: p < 0.0025, p < 0.0005 and p < 0.0005. DBcAMP + dexamethasone values, 2,4 and 6 hr 
versus control: p < 0.05, p < 0.0005 and p < 0.0005. DBcAMP + dexamethasone values, 2,4 and 6 hr versus DBcAMP: n.s. 
Adrenalectomy: Dexamethasone values, 2,4 and 6 hr versus control: p < 0.05, p < 0.005 and p < 0.005. DBcAMP values, 2,4 
and 6 hr versus control: p < 0.025, p < 0.0025 and ns. DBcAMP + dexamethasone values, 2,4 and 6 hr versus control: p < 0.0125, 
p < 0.0005 and p < 0.0005. DBcAMP + dexamethasone values, 2,4 and 6 hr versus DBcAMP: ns., p < 0.005 and p < 0.01. 
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perfusion. However, after 2 hr the further increase of 
PEP-CK activity ceased, but replacement of dexame- 
thasone in vitro at zero time restored the DBcAMP 
effect that was observed with livers from intact rats. 
Essentially the same results were obtained for 
TAT (tig.2). However, there were two differences 
interesting to note in comparison to PEP-CK: (i) The 
stimulation of TAT brought about by dexamethasone 
was more pronounced in both the livers of intact 
and of adrenalectomized rats. (ii) In intact animals 
combination of dexamethasone and DBcAMP revealed 
an additive effect on enzyme activity. 
4. Discussion 
CAMP and glucocorticoids induce PEP-CK and TAT 
in several systems: whole animals, perfused liver, 
fetal liver in organ culture and cultured hepatoma 
cells (for review see [9]). Recently we have demon- 
strated an interaction of both agents in the induction 
of liver PEP-CK and TAT in vivo by investigating the 
time course of enzyme activities after administration of 
DBcAMP and/or hydrocortisone into intact or 
adrenalectomized rats [ 11. In the present study the 
same concept was applied to the isolated perfused 
liver. 
The essential finding of the experiments presented 
in this paper is the striking similarity between the 
results obtained with the isolated perfused liver and 
those obtained previously with whole animals [ 11. 
(i) In the liver of intact rats PEP-CK and TAT activity 
was elevated by either DBcAMP or dexamethasone. 
(ii) The elevation provoked by DBcAMP initially 
occurred to the same degree in the liver of adrenalect- 
omized animals as well. (iii) However, the maintenance 
of DBcAMP-mediated stimulation of PEP-CK and TAT 
in the liver of adrenalectomized rats required the 
simultaneous presence of glucocorticoids. These 
findings indicate that the interaction of CAMP and 
glucocorticoids in the induction of PEP-CK and TAT 
occurs, in fact, at the tissue level. Moreover, they 
confirm our preliminary conclusions drawn from the 
in vivo study that CAMP elevates both enzymes by a 
mechanism which in principle works independently 
from ghrcocorticoids, while glucocorticoids stimulate 
a different process which is required for the mainte- 
nance of the CAMP-mediated enzyme induction. 
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At present the mode of interaction between CAMP 
and glucocorticoids in PEP-CK and TAT synthesis is not 
clear. An attractive hypothesis consistent with our 
results has been derived from studies on fetal rat liver 
in organ culture and cultured hepatoma cells [IO] : 
Glucocorticoids promote an increase in the level of 
PEP-CK and TAT templates while CAMP stimulates 
the translation of the preexisting templates. 
This hypothesis is in accordance with the results 
obtained by others in vitro: In Reuber hepatoma cells 
actinomycin D completely blocked the response of 
PEP-CK to dexamethasone but did not suppress the 
early increase of PEP-CK [ 1 l] and TAT [ 121 activity 
provoked by the addition of DBcAMP. However, con- 
flicting results have been obtained in vivo: as expected 
from this hypothesis actinomycin D inhibited the 
hydrocortisone-induced stimulation of hepatic PEP- 
CK [ 131 and TAT [ 141 in the liver of adrenalectomiz- 
ed rats. Also, despite of pretreatment of the animals 
with actinomycin D or 5-azacytidine, hepatic TAT 
was found to be stimulated by DBcAMP injection 
into neonatal [IS] and adult [ 161 rats, respectively. 
In contradiction to this hypothesis actinomycin D 
was reported to greatly inhibit [ 171 or totally block 
[ 181 the increase of TAT after glucagon or DBcAMP 
administration, respectively. 
Thus, the exact nature of the interaction between 
CAMP and glucocorticoids in the regulation of 
hepatic PEP-CK and TAT remains to be established. 
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